G laucoma is one of the leading causes of blindness worldwide. [1] [2] [3] [4] [5] The disease is caused by gradual degeneration of retinal ganglion cells and secondary loss of axons that carry visual information from the eyes to the brain. The reported glaucoma prevalence differs significantly, depending on race, age, and the population studied. 1-4,6 -9 Primary open-angle glaucoma accounts for more than half of all cases worldwide and far more than that in the Western world. POAG is a bilateral disease of slow onset that is characterized by atrophy of the optic nerve fibers (the retinal ganglion cell axons) as they pass through the region of optic disc and lamina cribrosa. This condition is frequently associated with elevated intraocular pressure (IOP). In low-pressure glaucoma (LPG), also known as normal-pressure glaucoma (NPG), glaucomatous optic nerve damage and visual field defects occur in association with IOPs within the normal range, although the progression of the damage is probably still IOP dependent. 10 LPG prevalence may account for between 10% and 50% of all POAG cases in persons over the age of 40, with the highest prevalence reported in Japan. [11] [12] [13] [14] Molecular studies of glaucoma-affected families have identified seven genetic loci for adult-onset POAG [15] [16] [17] [18] [19] [20] and three other loci for primary congenital glaucoma (Stoilov I, et al. IOVS 2002; 43 :ARVO E-Abstract 3015). 21, 22 However, until very recently, when we discovered optineurin (OPTN) 23 and WD40-repeat 36 (WDR36) 24 genes for adult-onset POAG, only two other glaucoma-causing genes had been identified: cytochrome P4501B1 (CYP1B1) for primary congenital glaucoma 25 and myocilin (MYOC) for POAG. 26 In 2002, we reported that mutations in the optineurin gene are involved mainly in lowpressure adult-onset POAG. 23 The molecular mechanisms of OPTN involvement in the development of glaucoma are not as yet understood. 27 We have shown secretion of the optineurin protein by trabecular meshwork (TM) and nonpigmented ciliary epithelium (NPCE) cell lines and its presence in aqueous humor. 23 We have also detected expression of this protein in human ocular tissues, with strong immunoreactivity in the ciliary body, ciliary muscle, cornea, iris, and retina. 27 Furthermore, we have mapped and cloned the OPTN counterpart in mouse and investigated the cellular and tissue localization of the protein in mouse eyes. 28 Our recent expression profiling of optineurin in the mouse revealed that this protein is expressed in very early stages of eye development. 28 In this report, we present molecular cloning and genomic organization of the Rh-OPTN gene and the localization and distribution of its protein in various ocular tissues of the rhesus monkey.
MATERIALS AND METHODS

Tissues and Antibodies
Eyes and other tissues used in this study were obtained from three rhesus monkeys (Macaca mulatta). All experiments were conducted in accordance with the guidelines given in the ARVO Statement for Use of Animals in Ophthalmic and Vision Research and under the auspices of the animal care and use committees of the University of Connecticut Health Center and University of Wisconsin-Madison. The animals were deeply anesthetized and perfused with 4% paraformaldehyde and 0.1% glutaraldehyde, as described previously. 29 The eyes were enucleated and processed for immunohistochemistry studies. A thin layer of rhesus monkey skin was used to establish a dermal fibroblast cell line. These cells were maintained in DMEM-F12 (Invitrogen-Gibco, Grand Island, NY), supplemented with 10% FBS, and 1% antimycotic (Invitrogen-Gibco) in an incubator at 37°C in 5% CO 2 . Whole blood was taken from one rhesus monkey, and the genomic DNA was extracted.
The primary antibody used in this study is an anti-OPTN antibody that has been raised against a polypeptide at the C terminus of the optineurin protein that is 100% conserved between human and monkeys.
cDNA Cloning and Genomic Organization of the
Rh-OPTN Gene
Total RNA was isolated from a cultured rhesus monkey dermal fibroblast cell line (TRIzol; Invitrogen, Carlsbad, CA), according to the manufacturer's protocol. Preparation of cDNA was performed by reverse transcriptase (RT)-PCR using a commercial kit (SuperScript FirstStrand Synthesis System; Invitrogen-Gibco). Rhesus monkey full-length cDNA was amplified by using primers designed based on human OPTN cDNA. PCR products were cloned into a TOPO-TA cloning vector (Invitrogen) and transformed into chemically competent Escherichia coli cells supplied by the manufacturer. Several clone inserts were sequenced in their entirety. The genomic DNA was isolated from a rhesus monkey blood sample with a kit (Gentra Systems, Inc., Minneapolis, MN). The exons and flanking DNA sequences of the Rh-OPTN gene were PCR amplified by using primers originally designed based on human genomic sequences (GenBank accession number AL355355; http://www.ncbi.nlm.nih.gov/Genbank; provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD). By using the dye terminator chemistry (BigDye; Applied Biosystems, Inc.
[ABI], Foster City, CA), all the DNA and cDNA sequencing experiments were performed bidirectionally, by using either an automated DNA sequencer (model 377; ABI) or a genetic analyzer (model 3100; ABI). Sequence analyses and alignments were performed with publicly available programs (i.e., BLAST 2 sequences at the National Center for Biotechnology Information, Bethesda, MD; http://www. ncbi.nlm.nih.gov/blast/bl2seq/bl2.html and ClustalW: Multiple Sequence Alignment at the Baylor College of Medicine (Houston, TX; http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html). The Rh-OPTN gene sequences obtained during the course of this study are now available in GenBank accession numbers AY228373 and AY228374 for the full-length cDNA, accession numbers AY749110 to AY749122 for genomic sequences of exons 1 to 13 and accession number AH014152 for the entire genomic sequence). The 13 coding exons in the rhesus monkey showed a very high degree of similarity and fully conserved intron-exon boundaries with the human OPTN gene. PCR primers and conditions are available on request.
Northern Blot Analysis
A rhesus monkey tissue Northern blot analysis (normalized by amount of mRNA) blot from Biochain Institute (Hayward, CA) was used for this study. The blot contained mRNA samples from seven tissues of heart, brain, kidney, lung, spleen, skeletal muscle, and small intestine of monkey as well as human adult placenta as a control. A cDNA probe covering amino acids 107-412 of the Rhesus monkey OPTN was amplified using forward primer of (5Ј-TTGAAGGAAGAGCTTGGAAAA-3Ј) and the reverse primer of (3Ј-CCACTTTTTCTGACTCTTTTCTTG-5Ј). The cDNA probe was labeled with fluorescein-12-dUTP (1 mM; Roche Diagnostics, Indianapolis, IN). The blot was prehybridized (FastHyb solution; Biochain) for 3 hours at 65°C and subsequently hybridized with the solution with the probe overnight. Membrane was washed with 1ϫ SSC/0.1% SDS at 65°C for 15 minutes and incubated with blocking solution at room temperature for 30 minutes. Membrane was incubated with antibody solution (anti-fluorescein alkaline phosphatase conjugates; 1:5000) for 30 minutes. After it was washed three times, the membrane was incubated with detection reagent at room temperature for 4 minutes and then was exposed to x-ray film for 3 minutes. The equality and integrity of RNA were confirmed by probing a membrane from the same lot with a fluorescein-labeled human ␤-actin cDNA probe.
Immunocytochemistry Analysis
Rhesus monkey dermal fibroblast cells were grown on glass coverslips in six-well plates for 48 hours. After they were washed with phosphatebuffered saline (PBS), the cells were fixed with 4% paraformaldehyde on ice and permeabilized in 0.1% Triton X-100. Nonspecific hybridization was blocked by incubation with 4% bovine serum albumin in PBS. Cells were incubated with primary antibody at 1:200 (optineurin antipeptide antibody raised in chicken), diluted in blocking solution for 1 hour, and rinsed in PBS. The secondary antibody, goat anti-chicken IgG (HϩL; Alexa 488; Molecular Probes, Eugene, OR), was diluted 1:500 in blocking solution and applied for 45 minutes. Nuclei were stained with TO-PRO-3 iodide (Molecular Probes) at 1:200 for 30 minutes. After a brief wash in PBS, the coverslips were mounted on slides (Prolong Antifade medium; Molecular Probes) to preserve fluorescence and visualized under a laser scanning confocal microscope (model 410; Carl Zeiss Meditec, Dublin, CA).
Immunohistochemistry Analysis
Eyes from a perfused rhesus monkey were postfixed for 2 hours in 4% paraformaldehyde in PBS at 4°C and subsequently processed for paraffin embedding. For immunohistochemistry experiments, specimens were sectioned into 5-m sections and mounted on poly-L-lysinecoated glass slides. Tissue sections were deparaffinized with xylene and rehydrated in a decreasing ethanol series. Nonspecific binding sites were blocked with incubation in blocking solution (Power Block; BioGenex, San Ramon, CA) for 10 minutes. The sections were subsequently incubated overnight at 4°C with primary anti-optineurin antibody (1:500 dilution in 0.1% BSA in PBS). After three brief washes with PBS, the sections were incubated for 45 minutes with the secondary antibody goat anti-chicken IgG (HϩL; Alexa 594; Molecular Probes) diluted 1:400 in 0.1% BSA in PBS. After a wash with PBS, sections were incubated with TO-PRO-3 iodide (Molecular Probes) at 1:400 for 30 minutes. After washing in PBS, the specimens were mounted (Prolong Antifade; Molecular Probes) to preserve fluorescence and visualized under the laser scanning confocal microscope. Control experiments for nonspecific staining included replacement of the primary anti-OPTN antibody with preimmune serum from the same chicken in which the antibody was raised.
RESULTS
Isolation and Characterization of the Rhesus Monkey Optineurin Gene
The Rh-OPTN full-length cDNA was amplified with primers originally designed from the 3Ј and 5Ј ends of the human optineurin gene. A PCR product of approximately 2.0-kb was cloned into the TOPO-TA cloning vector, and several insert clones were subsequently sequenced in their entirety. Two lines of clones were identified and designated variants 2 and 3, as they were compatible with the human OPTN isoforms 2 and 3, respectively. Similar to human optineurin cDNA, these two variants also resulted from different splicing of the noncoding exons at the 5Ј untranslated region of the Rh-OPTN gene. The nucleotide and deduced amino acid sequences for Rh-OPTN variant 2 are presented in (Fig. 1) .
The obtained 1925-and 2076-bp sequences of rhesus monkey OPTN variants 2 and 3 are 96% identical with their counterparts of human isoforms 2 and 3, respectively. Both of these Rh-OPTN sequences translate into a 571 amino acid protein that is 96% identical with the human OPTN protein (Fig. 2) .
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Genomic Organization of the Rhesus Monkey OPTN Gene
An orthologue to the human optineurin gene was PCR amplified from rhesus monkey genomic DNA by using human oligonucleotide primers. Alignment of the obtained sequences for the Rh-OPTN cDNA with its human orthologue revealed the presence of 13 coding exons ranging in sizes from 74 to 203 bp ( Table 1) . The location and sequence of the intron-exon boundaries were fully conserved with its human counterpart for all the 13 coding exons, except for the splicing acceptor site at exon 5. In rhesus monkey, the first six amino acids of exon 5 were spliced out due to a different acceptor-splicing site that has been created by a single base sequence change. All the observed splice acceptor and donor sites were in accordance with the consensus GT-AG rule (Table 1 ; see also GenBank accession number AH014152). The predicted Rh-OPTN protein contains conserved coiled-coil and C2H2-Zn finger domains, as has been reported for the human OPTN.
Northern Blot Analysis
The tissue distribution and expression profiling of monkey optineurin was examined by Northern blot analysis of an mRNA multiple tissue blot (BioChain). As shown in Figure 3 , two different transcripts showed prominent expression (arrows) that is consistent with presence of two OPTN cDNA variants in rhesus monkey (GenBank Accession numbers of AY228373-4). The highest expression of monkey OPTN was observed in skeletal muscle, which is very similar to its human counterpart as reported previously. Expression of OPTN in heart, brain, kidney, lung, and skeletal muscle is comparable among human, mouse, and monkey.
28,30
Immunocytochemistry Analysis
Rhesus monkey dermal fibroblasts showed a strong positive staining for the optineurin protein in immunocytochemistry analysis with the anti-optineurin antibody (Fig. 4) . The endog- 
Expression Profiling of Rh-OPTN Protein in Ocular Tissues
Tissue distribution of the Rh-OPTN protein was determined by immunohistochemical labeling of paraffin-embedded sections of rhesus monkey eyes and optic nerve using an anti-optineurin antibody. Intense staining was observed in iris anterior epithelium, constrictor muscle, and endothelial cells of the iris blood vessels (Fig. 5A ). In the anterior segment, positive immunoreactivity was observed in trabecular meshwork, nonpigmented ciliary epithelium, ciliary muscle, and Schlemm's canal endothelium (Fig. 5B) . In the retina, prominent staining was detected in the nerve fiber; ganglion cell, and inner and outer plexiform layers; the cell bodies of rods and cones (Fig. 5C) ; and, most intensely, in the retinal pigmented epithelium. Ax- Nucleotides in upper and lower case letters represent exon and intron sequences, respectively. *According to the rhesus monkey OPTN gene (GenBank Accession number AY228373).
ons of the optic nerve ganglion cells, astrocytes, glial cells, and endothelial cells of the optic nerve blood vessels also stained for optineurin (Figs. 5D-F) . No labeling was observed in any of the control sections tested.
DISCUSSION
Our previous studies determined an association between mutations in the human OPTN gene and adult-onset POAG. 23, 27 We also mapped, cloned, and characterized the mouse Optn gene, its protein products and determined its ocular expression patterns. 28 Before this study, organization and expression of the OPTN gene in primates other than humans was unknown. In the present study, the complete cDNA sequence, genomic structure, mRNA, and protein expression profiles of the monkey optineurin gene were established. The Rh-OPTN gene is nearly identical with its human counterpart in both genomic structure and amino acid sequence. The mRNA expression pattern of Rh-OPTN is highly similar to previous reports for its homologous genes in human 30 and mouse. 28 Identification of two highly expressed transcripts (Fig. 3A) is in full agreement with the two observed isoforms by cDNA cloning. The mRNA expression patterns of OPTN in heart, brain, kidney, lung, and skeletal muscle are consistent in human, monkey, and mouse. 28, 30 Similar to the human gene, the highest expression was observed in skeletal muscle.
This study revealed that intracellular localization and ocular expression profiles of Rh-OPTN protein is consistent with its homologous protein in mouse and human. 23, 27, 28 The Rh-OPTN gene shares 96% homology in cDNA and predicted amino acid sequences with its human counterpart. OPTN has now been shown to be an evolutionarily conserved gene, as determined by our molecular cloning and expression profiling of its protein products in mouse, 28 monkey, and human. 23, 27 OPTN conservation is also confirmed in pigs (Obazawa M, et al. IOVS 2003;44:ARVO E-Abstract 1115) which shows a high homology (84%) between both polypeptide sequences and transcript expressions in trabecular meshwork cells and astrocytes, as previously described for its human homologous gene. 23, 27 The expression pattern of OPTN protein in ocular tissues of the rhesus monkey is highly similar to our observation in human eyes 27 (and unpublished data). Similar to this study, in the human eye, positive staining for optineurin protein has been observed in vascular endothelium, trabecular meshwork, Schlemm's canal, iris constrictor muscle, ciliary muscle, nonpigmented ciliary epithelium of the anterior segment, nerve fiber layer, ganglion cell layer, inner and outer plexiform layers, and retinal pigmented epithelium (manuscript in preparation).
Although the function of human OPTN protein still remains to be determined, the presence of identical functional protein domains, high conservation of the gene structures and sequences, similar ocular expressions and localization of OPTN in rhesus monkey and human are all consistent with the role of this gene in the etiology of glaucoma, as previously reported for several mutations in the human OPTN gene. 23, [31] [32] [33] [34] The rhesus monkey has been used extensively as a model for human diseases and drug trials because of its similarities to the human. Great similarities in eye development and function between monkey and human makes this animal a suitable model for human visual research and pharmacological evaluation of glaucoma therapy. A recent microarray analysis 35 identified a high homology and identity (95%) between monkey and human coding genes. Similarly, a high degree of gene conservation exist between cynomolgus monkey and human. 36 Several studies of an induced-glaucoma model in primates have illustrated common characteristic features with its human phenotype. [37] [38] [39] [40] A gene expression analysis of retina in a monkey glaucoma model showed that most of the genes investigated had expression profiles similar to those of the human and only 0.7% of the 9182 genes analyzed were either up-or downregulated. 41 Cloning and characterization of the rhesus monkey OPTN gene facilitates comparison and conservation of amino acid residues that have been mutated in vari- ous forms of glaucoma. This study may also contribute to better understanding of optineurin gene expression, function, and molecular mechanisms that eventually lead to the glaucoma phenotype.
